Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MacDonald

Showing results (1021-1030 of 1,067) with videos related to

Pageof 107
Sort By:
Ecology Letters|May 24, 2022
Temporal correlations among demographic parameters are ubiquitous but highly variable across speciesRémi Fay, Sandra Hamel, Martijn van de Pol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in AdultsPatrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
Nature Communications|October 30, 2022
Genome-wide rare variant score associates with morphological subtypes of autism spectrum disorderAda J S Chan, Worrawat Engchuan, Miriam S Reuter, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Cell Reports|November 8, 2018
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human PrimatesJennifer R Keeffe, Koen K A Van Rompay, Priscilla C Olsen, et al.
JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2017
Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart FailureYvonne May Fen Chia, Tiew-Hwa Katherine Teng, Eugene S J Tan, et al.
JAMA Oncology|June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 TrialErica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Human Molecular Genetics|May 8, 2023
Gene copy number variation and pediatric mental health/neurodevelopment in a general populationMehdi Zarrei, Christie L Burton, Worrawat Engchuan, et al.
Science (New York, N.Y.)|October 14, 2021
Replication and single-cycle delivery of SARS-CoV-2 repliconsInna Ricardo-Lax, Joseph M Luna, Tran Thi Nhu Thao, et al.
Pageof 107

Showing results (1021-1030 of 1,067) with videos related to

Sort By:
Pageof 107
Ecology Letters|May 24, 2022
Temporal correlations among demographic parameters are ubiquitous but highly variable across speciesRémi Fay, Sandra Hamel, Martijn van de Pol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in AdultsPatrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
Nature Communications|October 30, 2022
Genome-wide rare variant score associates with morphological subtypes of autism spectrum disorderAda J S Chan, Worrawat Engchuan, Miriam S Reuter, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Cell Reports|November 8, 2018
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human PrimatesJennifer R Keeffe, Koen K A Van Rompay, Priscilla C Olsen, et al.
JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2017
Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart FailureYvonne May Fen Chia, Tiew-Hwa Katherine Teng, Eugene S J Tan, et al.
JAMA Oncology|June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 TrialErica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Human Molecular Genetics|May 8, 2023
Gene copy number variation and pediatric mental health/neurodevelopment in a general populationMehdi Zarrei, Christie L Burton, Worrawat Engchuan, et al.
Science (New York, N.Y.)|October 14, 2021
Replication and single-cycle delivery of SARS-CoV-2 repliconsInna Ricardo-Lax, Joseph M Luna, Tran Thi Nhu Thao, et al.
Pageof 107